Thermodynamics of complexes formation by ITC in methanol/water = 9/1 (v/v) solution: A case study

Thermochimica Acta

Volumn 586, Issue , 2014, Pages 40-44

  Fisicaro, Emilia ^a   Compari, Carlotta ^a   Bacciottini, Franco ^a   Contardi, Laura ^a   Carcelli, Mauro ^a   Rispoli, Gabriele ^a   Rogolino, Dominga ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Antiretroviral drug; Complexes formation heats; HIV integrase inhibitor; Isotermal titration calorimetry in mixed solvent; Mg(II), Mn(II), Co(II) and Zn(II) complexes; Raltegravir

Indexed keywords

BINDING ENERGY; CALORIMETERS; CHLORINE COMPOUNDS; COBALT COMPOUNDS; DISEASES; ENZYMES; FREE ENERGY; MAGNESIUM COMPOUNDS; MANGANESE COMPOUNDS; METAL IONS; METALS; METHANOL; NUCLEIC ACIDS; ORGANIC SOLVENTS; POTASSIUM COMPOUNDS; TITRATION; VIRUSES;

ANTIRETROVIRAL DRUGS; FORMATION HEAT; HIV INTEGRASE INHIBITORS; MIXED SOLVENT; RALTEGRAVIR; ZN COMPLEX;

ZINC COMPOUNDS;

EID: 84899890160     PISSN: 00406031     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tca.2014.04.003     Document Type: Article

References (40)

1. P.C.A. Bruijnincx, and P.J. Sadler New trends for metal complexes with anticancer activity Curr. Opin. Chem. Biol. 12 2008 197 206
2. Chi-Ming Che, and Fung-Ming Siu Metal complexes in medicine with a focus on enzyme inhibition Curr. Opin. Chem. Biol. 14 2010 255 261
3. P.J. Sadler, and Z. Guo Metal complexes in medicine: design and mechanism of action Pure Appl. Chem. 70 4 1998 863 871 (Pubitemid 128484355)
4. B. Singh Sekhon Inorganics/bioinorganics: biological, medicinal and pharmaceutical uses J. Pharm. Educ. Res. 2 1 2011
5. K.H. Thompson, and C. Orvig Boon and bane of metal ions in medicine Science 300 2003 936
6. Dik-Lung Ma, Hong-Zhang He, Ka-Ho Leung, D. Shiu-Hin Chan, and Chung-Hang Leung Bioactive luminescent transition-metal complexes for biomedical applications Angew. Chem. Int. Ed. 52 2013 7666 7682
7. A. Bacchi, M. Carcelli, C. Compari, E. Fisicaro, N. Pala, G. Rispoli, D. Rogolino, T.W. Sanchez, M. Sechi, V. Sinisi, and N. Neamati Investigating the role of metal chelation in HIV-1 integrase strand transfer inhibitors J. Med. Chem. 54 2011 8407 8420
8. A. Bacchi, M. Biemmi, M. Carcelli, F. Carta, C. Compari, E. Fisicaro, D. Rogolino, M. Sechi, M. Sippel, C.A. Sotriffer, T.W. Sanchez, and N. Neamati From ligand to complexes. Part 2. Remarks on human immunodeficiency virus type 1 integrase inhibition by diketo acid metal complexes J. Med. Chem. 51 2008 7253 7264
9. M. Sechi, A. Bacchi, M. Carcelli, C. Compari, E. Duce, E. Fisicaro, D. Rogolino, P. Gates, M. Derudas, L.Q. Al-Mawsawi, and N. Neamati From ligand to complexes: inhibition of human immunodeficiency virus type 1 integrase by α-Diketo acid metal complexes J. Med. Chem. 49 2006 4248 4260 (Pubitemid 44036668)
10. A. Bacchi, M. Carcelli, C. Compari, E. Fisicaro, N. Pala, G. Rispoli, D. Rogolino, T.W. Sanchez, M. Sechi, and N. Neamati HIV-1 IN strand transfer chelating inhibitors: a focus on metal binding Mol. Pharm. 8 2011 507 519
11. P.O. Brown J.C. Coffin, S.H. Hughes, H.E. Varmus, Integration. In RetroViruses 1999 Cold Spring Harbor Press Plainview, NY
12. D. Esposito, and R. Craigie Integrase structure and function Adv. Virus Res. 52 1999 319 333
13. E. Asante-Appiah, and A.M. Skalka A molecular mechanisms in retrovirus DNA integration Antiviral Res. 36 1997 139
14. N. Neamati Structure-based HIV-1 integrase inhibitor design: a future perspective Expert Opin. Investig. Drugs 10 2001 281 296 (Pubitemid 32117937)
15. N.J. Anthony HIV-1 integrase: a target for new AIDS chemotherapeutics Curr. Top. Med. Chem. 4 2004 979 990 (Pubitemid 38854850)
16. Y. Pommier, A.A. Johnson, and C. Marchand Integrase inhibitors to treat HIV/AIDS Nat. Rev. Drug Discov. 4 2005 236 248 (Pubitemid 40372557)
17. R. Dayam, and N. Neamati Small-molecule HIV-1 integrase inhibitors: the 2001-2002 update Curr. Pharm. Des. 9 2003 1789 1802 (Pubitemid 36958350)
18. R. Dayam, J. Deng, and N. Neamati HIV-1 integrase inhibitors: 2003-2004 update Med. Res. Rev. 26 2006 271 309
19. R. Dayam, R. Gundla, L.Q. Al-Mawsawi, and N. Neamati HIV-1 integrase inhibitors: 2005-2006 update Med. Res. Rev. 28 2008 118 154 (Pubitemid 350274962)
20. P. Cotelle Patented HIV-1 integrase inhibitors (1998-2005), recent patents anti-infect Drug Discov. 1 2006 1 15
21. A.A. Johnson, C. Marchand, and Y. Pommier HIV-1 integrase inhibitors: a decade of research and two drugs in clinical trial Curr. Top. Med. Chem. 4 2004 671 686
22. E. Zeinalipour-Loizidou, C. Nicolaou, A. Nicolaides, and L.G. Kostrikis HIV-1 integrase: from biology to chemotherapeutics Curr. HIV Res. 5 2007 365 388 (Pubitemid 47044734)
23. D.J. Hazuda, P. Felock, M. Witmer, A. Wolfe, K. Stillmock, J.A. Grobler, A. Espeseth, L. Gabryelski, W. Schleif, C. Blau, and M.D. Miller Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells Science 287 2000 646 650 (Pubitemid 30070911)
24. Y. Goldgur, R. Craigie, G.H. Cohen, T. Fujiwara, T. Yoshinaga, T. Fujishita, H. Sugimoto, T. Endo, H. Murai, and D.R. Davies Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design Proc. Natl. Acad. Sci. U.S.A. 96 1999 13040 13043
25. G.C.G. Pais, and T.R. Burke Novel aryl diketo-containing inhibitors of HIV-1 integrase Drugs Future 27 2002 1101 1111 (Pubitemid 36187861)
26. Y. Wang, N. Serradell, J. Bolos, and E. Rosa MK-0518, HIV integrase inhibitor Drugs Future 32 2007 118 122
27. M. Rowley The discovery of Raltegravir, an integrase inhibitor for the treatment of HIV infection Prog. Med. Chem. 46 2008 1 28
28. B. Grinsztein, B.-Y. Nguyen, C. Katlama, J.M. Gatell, A. Lazzarin, V. Vittecoq, C.J. Gonzalez, J. Chen, C.M. Harvey, and R.D. Isaacs Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial Lancet 369 2007 1261 1269 (Pubitemid 46553846)
29. L.A. Sorbera, and N. Serradell GS-9137. Anti-HIV agent, HIV integrase inhibitor Drugs Future 31 2006 310 313
30. M. Sato, T. Motomura, H. Aramaki, T. Matsuda, M. Yamashita, Y. Ito, H. Kawakami, Y. Matsuzaki, W. Watanabe, K. Yamataka, S. Ikeda, E. Kodama, M. Matsuoka, and H. Shinkai Novel HIV-1 integrase inhibitors derived from quinolone antibiotics J. Med. Chem. 49 2006 1506 1508 (Pubitemid 43376497)
31. J.E. Ladbury, G. Klebe, and E. Freire Adding calorimetric data to decision making in lead discovery: a hot tip Nat.Rev./Drug Discov. 9 2010 23 27
32. K. Rajarathnam, and J. Rösgen Isothermal titration calorimetry of membrane proteins - progress and challenges Biochim. Biophys. Acta 2013 10.1016/j.bbamem.2013.05.023
33. R. Ghai, R.J. Falconer, and B.M. Collins Applications of isothermal titration calorimetry in pure and applied research-survey of the literature from 2010 J. Mol. Recognit. 25 2012 32 52
34. G. Gran Determination of the equivalence point in potentiometric titrations II, Analyst (London) 77 1952 661
35. E. Fisicaro, and A. Braibanti Potentiometric Titrations in Methanol/Water Medium: Intertitration Variability Talanta 10 1988 769
36. D. Rogolino, M. Carcelli, M. Sechi, and N. Neamati Viral enzymes containing magnesium: metal binding as a successful strategy in drug design Coord. Chem. Rev. 256 2012 3063 3086
37. J.A. Cowan Metal activation of enzymes in nucleic acid biochemistry Chem. Rev. 96 1998 1067 1087 (Pubitemid 128632237)
38. S.A. Myers, A. Nield, and M. Myers Zinc transporters, mechanism of action and therapeutic utility: implications for type 2 diabetes mellitus J. Nutr. Metabol. 2012 10.1155/2012/173712 13 p. (article ID 173712)
39. P. Gans, A. Sabatini, and A. Vacca Simultaneous calculation of equilibrium constants and standard formation enthalpies from calorimetric datafor system with multiple equilibria in solution J. Solution Chem. 37 2008 467 476
40. M. Carcelli, D. Rogolino, M. Sechi, G. Rispoli, E. Fisicaro, C. Compari, E. Tramontano, L. Naesens, Antiretroviral activity of metal-based HIV-1 integrase inhibitors (submitted for publication).